Alexander Azoy sold $49k of RCUS
Chief Accounting Officer at Arcus Biosciences, Inc.. 1,900 shares at an average of $26.00, traded Nov 26, 2025, filed Dec 1, 2025.
Score components
- +15RoleOfficer
- +7Trade size$49k at market
- 0Share of holdings soldSold 6.5% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001771961-25-000009, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 26, 2025 | MOption exercise Common Stock10b5-1 | +1,900 | $13.33 | $25k | 29,263 | Dec 1, 2025 |
| Nov 26, 2025 | SOpen-market sale Common Stock10b5-1 | -1,900 | $26.00 | $49k | 27,363 | Dec 1, 2025 |
| Nov 26, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,900 | $0.00 | $0 | 9,500 | Dec 1, 2025 |
Related signals
Other insiders at Arcus Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | Arcus Biosciences, Inc. | Terry J Rosen Chief Executive Officer | $1.2M 54,691 shares | -2% | |
| 32Weak | Arcus Biosciences, Inc. | Juan C. Jaen President | $467k 21,208 shares | -6% | |
| 36Weak | Arcus Biosciences, Inc. | Robert C. Goeltz II Chief Financial Officer | $279k 12,662 shares | -15% | |
| 32Weak | Arcus Biosciences, Inc. | Jennifer Jarrett Chief Operating Officer | $467k 21,208 shares | -10% | |
| 32Weak | Arcus Biosciences, Inc. | Alexander Azoy Chief Accounting Officer | $195k 8,832 shares | -32% | |
| 29Weak | Arcus Biosciences, Inc. | Carolyn C. Tang General Counsel | $318k 14,468 shares | -10% | |
| 27Weak | Arcus Biosciences, Inc. | Richard Markus Chief Medical Officer | $210k 9,546 shares | -13% | |
| 40Moderate | Arcus Biosciences, Inc. | Juan C. Jaen President | $2.1M 82,997 shares | -8% | |
| 27Weak | Arcus Biosciences, Inc. | Robert C. Goeltz II Chief Financial Officer | $125k 5,000 shares | -5% | |
| 40Moderate | Arcus Biosciences, Inc. | Juan C. Jaen President | $1.0M 50,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.